DocGo Inc. Finance Lease, Right-of-Use Asset, Amortization
DocGo Inc. (DCGO) reported Finance Lease, Right-of-Use Asset, Amortization of $1.39 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-17
- DocGo Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $1.39M, a 5.62% increase year-over-year.
- DocGo Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $1.36M, a 9.51% increase year-over-year.
- DocGo Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $1.38M, a 13.28% increase year-over-year.
- DocGo Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $1.27M, a 6.32% increase year-over-year.
- DocGo Inc. finance lease, right-of-use asset, amortization for fiscal 2025 was $5.22M, a 12.97% increase from fiscal 2024.
- DocGo Inc. finance lease, right-of-use asset, amortization for fiscal 2024 was $4.62M, a 27.32% decline from fiscal 2023.
- DocGo Inc. finance lease, right-of-use asset, amortization for fiscal 2023 was $6.35M, a 96.29% increase from fiscal 2022.
- DocGo Inc. finance lease, right-of-use asset, amortization for fiscal 2022 was $3.24M, a 11.07% increase from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.39M 10-Q · filed 2026-08-17 | $2.75M 10-Q · filed 2026-08-17 | $4.14M derived: sum of 3 quarters · filed 2026-08-17 | $5.41M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $1.36M 10-Q · filed 2026-05-11 | $2.74M derived: sum of 2 quarters · filed 2026-05-11 | $4.02M derived: sum of 3 quarters · filed 2026-05-11 | $5.33M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.66M derived: sum of 2 quarters · filed 2026-03-16 | $3.97M derived: sum of 3 quarters · filed 2026-08-17 | $5.22M 10-K · filed 2026-03-16 |
| 2025-09-30 | $1.27M 10-Q · filed 2025-11-10 | $2.59M derived: sum of 2 quarters · filed 2026-08-17 | $3.83M 10-Q · filed 2025-11-10 | $5.05M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $1.32M 10-Q · filed 2026-08-17 | $2.56M 10-Q · filed 2026-08-17 | $3.78M derived: sum of 3 quarters · filed 2026-08-17 | $4.98M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $1.24M 10-Q · filed 2026-05-11 | $2.46M derived: sum of 2 quarters · filed 2026-05-11 | $3.66M derived: sum of 3 quarters · filed 2026-05-11 | $4.80M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.42M derived: sum of 2 quarters · filed 2026-03-16 | $3.56M derived: sum of 3 quarters · filed 2026-03-16 | $4.62M 10-K · filed 2026-03-16 |
| 2024-09-30 | $1.20M 10-Q · filed 2025-11-10 | $2.34M derived: sum of 2 quarters · filed 2025-11-10 | $3.39M 10-Q · filed 2025-11-10 | $6.92M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | $1.14M 10-Q · filed 2025-08-07 | $2.20M 10-Q · filed 2025-08-07 | $5.73M derived: sum of 3 quarters · filed 2026-03-16 | $6.92M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | $1.06M 10-Q · filed 2025-05-08 | $4.59M derived: sum of 2 quarters · filed 2026-03-16 | $5.78M derived: sum of 3 quarters · filed 2026-03-16 | $6.61M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $3.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $4.73M derived: sum of 2 quarters · filed 2026-03-16 | $5.55M derived: sum of 3 quarters · filed 2026-03-16 | $6.35M 10-K · filed 2026-03-16 |
| 2023-09-30 | $1.20M 10-Q · filed 2024-11-07 | $2.02M derived: sum of 2 quarters · filed 2024-11-07 | $2.82M 10-Q · filed 2024-11-07 | $3.67M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $826.18K 10-Q · filed 2024-08-07 | $1.63M 10-Q · filed 2024-08-07 | $2.47M derived: sum of 3 quarters · filed 2025-02-27 | $3.35M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $801.08K 10-Q · filed 2024-05-08 | $1.65M derived: sum of 2 quarters · filed 2025-02-27 | $2.52M derived: sum of 3 quarters · filed 2025-02-27 | $3.18M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $844.43K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.72M derived: sum of 2 quarters · filed 2025-02-27 | $2.38M derived: sum of 3 quarters · filed 2025-02-27 | $3.24M 10-K · filed 2025-02-27 |
| 2022-09-30 | $873.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $1.54M derived: sum of 2 quarters · filed 2023-11-06 | $2.39M 10-Q · filed 2023-11-06 | $2.92M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $662.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.52M 10-Q · filed 2023-08-08 | $2.05M derived: sum of 3 quarters · filed 2024-02-28 | $2.92M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $855.78K 10-Q · filed 2023-05-09 | $1.39M derived: sum of 2 quarters · filed 2024-02-28 | $2.25M derived: sum of 3 quarters · filed 2024-02-28 | $3.12M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $529.99K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.40M derived: sum of 2 quarters · filed 2024-02-28 | $2.27M derived: sum of 3 quarters · filed 2024-02-28 | $2.91M 10-K · filed 2024-02-28 |
| 2021-09-30 | $868.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.74M derived: sum of 2 quarters · filed 2022-11-08 | $2.38M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $868.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.52M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $646.81K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $2.18M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |